Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 13/22 Podcast
  4. Selective COX-2 inhibitors and risk of myocardial infarction
Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are
highly effective anti-inflammatory and analgesic drugs that exert
their action by preventing the formation of prostanoids. Recently
some coxibs, which were designed to exploit the advantageous
effects of non- steroidal anti-inflammatory drugs while evading
their side effects, have been reported to increase the risk of
myocardial infarction and atherothrombotic events. This has led to
the withdrawal of rofecoxib from global markets, and warnings have
been issued by drug authorities about similar events during the use
of celecoxib or valdecoxib/ parecoxib, bringing about questions of
an inherent atherothrombotic risk of all coxibs and consequences
that should be drawn by health care professionals. These questions
need to be addressed in light of the known effects of selective
inhibition of COX- 2 on the cardiovascular system. Although COX- 2,
in contrast to the cyclooxygenase-1 ( COX- 1) isoform, is regarded
as an inducible enzyme that only has a role in pathophysiological
processes like pain and inflammation, experimental and clinical
studies have shown that COX- 2 is constitutively expressed in
tissues like the kidney or vascular endothelium, where it executes
important physiological functions. COX- 2- dependent formation of
prostanoids not only results in the mediation of pain or
inflammatory signals but also in the maintenance of vascular
integrity. Especially prostacyclin ( PGI(2)), which exerts
vasodilatory and antiplatelet properties, is formed to a
significant extent by COX- 2, and its levels are reduced to less
than half of normal when COX- 2 is inhibited. This review outlines
the rationale for the development of selective COX- 2 inhibitors
and the pathophysiological consequences of selective inhibition of
COX- 2 with special regard to vasoactive prostaglandins. It
describes coxibs that are currently available, evaluates the
current knowledge on the risk of atherothrombotic events associated
with their intake and critically discusses the consequences that
should be drawn from these insights. Copyright (C) 2005 S. Karger
AG, Basel.
Episode melden

„Selective COX-2 inhibitors and risk of myocardial infarction“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz